Polysomnography

Eisai’s Marketing Authorization Application for Potential Insomnia Disorder Treatment Lemborexant Submitted in Japan

New Delhi, March 08, 2019: Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for…

5 years ago

Eisai to Give Oral Presentation on Results of Phase III Head-to-Head Clinical Study of Lemborexant in Insomnia Disorder

At 43rd Annual Meeting of The Japan Society of Sleep Research At “Drug Discovery Research For Sleep Medicine” Symposium Tokyo,…

6 years ago

Sleep disorder by Dr Kashmira Jhala (MD, Chest Medicine), Sr. Consultant Pulmonologist, Apollo Hospitals, Ahmedabad on ‘World Sleep Day’

New Delhi, March 16, 2018: Sleep disorder breathing is major but neglected health issue as snoring is believed to be normal and…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420